METHOD FOR TREATMENT OF OPTIC NERVE ATROPHY WITH OPTIC DISC DRUSEN Russian patent published in 2023 - IPC A61F9/07 A61N2/12 A61N1/30 A61K31/44 A61K31/51 A61K31/4015 A61K38/01 A61K38/08 A61P27/02 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be used for the treatment of optic nerve atrophy with optic nerve disc drusen (OND). To do this, 1 time a day for 10 days, 1% emoxypine, 0.5 ml, is administered parabulbarly, 20% piracetam, 5.0 ml, intravenously, cerebrolysin, 2.0 ml, intramuscularly, 0.05% proserin, 1.0 ml, intramuscularly. From the first day of treatment, 10 sessions of magnetotherapy are performed once a day on the closed eyelids and temporal region with intermittent exposure mode with induction of 6 mT, frequency of 12 Hz for 20 minutes. And also 10 sessions of endonasal electrophoresis with 0.1% semax from the positive pole are carried out within 5 minutes. The drugs are administered in a row in the specified sequence, and the interval between the introduction of all drugs and the physiotherapy procedures: electrophoresis and magnetotherapy is 30 minutes. At the same time, magnetic therapy is performed first, and electrophoresis is performed after 10 minutes.

EFFECT: invention provides an improvement in visual functions in this category of patients due to good penetration of drugs, low pharmacological load on the body and the achievement of a more pronounced and long-lasting effect of the treatment.

1 cl, 1 ex